BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3157961)

  • 1. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
    Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
    Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
    Tzouvelekis LS; Tzelepi E; Kaufmann ME; Mentis AF
    J Med Microbiol; 1994 Jun; 40(6):403-7. PubMed ID: 8006932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septicaemia caused by an Enterobacter cloacae strain varying in resistance against cephalosporins.
    Andersen BM; Dahl IM; George RC; Gilfillian A
    Infection; 1989; 17(3):156-9. PubMed ID: 2737758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Failure of new beta-lactam antibiotics in the treatment of severe Enterobacter cloacae infections].
    Perronne C; Régnier B; Legrand P; Buré A; Frottier J; Vildé JL; Vachon F
    Presse Med; 1986 Oct; 15(36):1813-8. PubMed ID: 2947158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactamase activity and cross-resistance to different cephalosporins of in vitro selected cefamandole-resistant variants of Enterobacter cloacae.
    Vuye A
    J Pharm Belg; 1982; 37(4):267-72. PubMed ID: 6982969
    [No Abstract]   [Full Text] [Related]  

  • 7. The emergence of resistance and the therapy of septicaemia.
    Phillips I; Shannon K
    Chemioterapia; 1985 Feb; 4(1):90-4. PubMed ID: 3986947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
    Rodríguez-Martínez JM; Fernández-Echauri P; Fernández-Cuenca F; Diaz de Alba P; Briales A; Pascual A
    J Antimicrob Chemother; 2012 Jan; 67(1):64-8. PubMed ID: 22001269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
    Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G
    Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility and beta-lactamase production in clinical isolates of Enterobacter spp.
    Lindh E; Dornbusch K; Jalakas K; Forsgren A
    APMIS; 1990 May; 98(5):462-70. PubMed ID: 2162681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
    Svarva PL; Lyng RV; Maeland JA
    Scand J Infect Dis; 1985; 17(4):387-91. PubMed ID: 3911375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ways to overcome cephalosporinase-mediated beta-lactam resistance in Enterobacter cloacae.
    Then RL; Angehrn P
    Chemioterapia; 1985 Feb; 4(1):83-9. PubMed ID: 3872727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance.
    Olson B; Weinstein RA; Nathan C; Kabins SA
    J Antimicrob Chemother; 1983 Apr; 11(4):299-310. PubMed ID: 6602122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.
    Chow JW; Fine MJ; Shlaes DM; Quinn JP; Hooper DC; Johnson MP; Ramphal R; Wagener MM; Miyashiro DK; Yu VL
    Ann Intern Med; 1991 Oct; 115(8):585-90. PubMed ID: 1892329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance in gram-negative bacteria: enterobacteriaceae.
    Paterson DL
    Am J Med; 2006 Jun; 119(6 Suppl 1):S20-8; discussion S62-70. PubMed ID: 16735147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis.
    Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ
    Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
    Neu HC; Chin NX
    Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.